Top Markets
Coin of the day
Jeisys Medical Inc. Jeisys Medical Inc.

Jeisys Medical Inc.

287410
Rang in Aktien #11661
Jeisys Medical Inc. is a company dedicated to the innovation and production of... Jeisys Medical Inc. is a company dedicated to the innovation and production of medical equipment, catering to a range of healthcare professionals including plastic surgeons, dermatologists, and other clinicians. Operating from its headquarters in Seoul, South Korea, the firm serves both its domestic market and international clients. Its comprehensive product line addresses various aesthetic and dermatological concerns, offering solutions for skin revitalization, firming, pigment correction, fat reduction, acne treatment, tattoo removal, and the management of scars and stretch marks. These advanced systems are branded under names such as ULTRAcel Q+, Cellec V, LIPOcel, AcGen, TRI-BEAM Premium, Edge ONE, SmoothCool, and ULTRAcel. The company distributes its offerings through an extensive network of partners. Jeisys Medical Inc. was established in 2001.
Aktienkurs
$8.92
Zuletzt synchronisiert: 2024-10-18
Marktkapitalisierung
$674.03M
Veränderung (1 Tag)
-5.14%
Veränderung (1 Jahr)
0.00%
Land
KR
Handel Jeisys Medical Inc. (287410)

Kategorie

P/B-Verhältnis für Jeisys Medical Inc. (287410)
P/B-Verhältnis zum August 2026 TTM: 10.27
Laut den neuesten Finanzberichten und dem Aktienkurs von Jeisys Medical Inc. beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 10.27. Am Ende des Jahres 2022 lag das P/B-Verhältnis bei 7.80.
P/B-Verlauf für Jeisys Medical Inc. von 2019 bis 2026
P/B-Verhältnis zum Jahresende
Jahr P/B-Verhältnis ändert
2026 (TTM) 10.27 22.51%
2023 8.38 7.43%
2022 7.80 -32.18%
2021 11.50 -34.15%
2020 17.47 0.00%
2019 0.00 0.00%
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/B-Verhältnis P/B-Verhältnis-Differenz Land
3.7944 -63.04%
US
5.423 -47.18%
US
2.0146 -80.38%
IE
3.072 -70.08%
US
- -
DE